Company intelligence / Profile preview

Cathay International Holdings Limited

Hong Kong, Hong Kong

Ownership: Private
Development stage: Other

Overview

Cathay International Holdings Limited is an investment holding company focused on pharmaceutical, healthcare, and cosmeceutical businesses, primarily operating in the People's Republic of China. Through its subsidiaries like Lansen, it develops and commercializes pharmaceutical products (e.g., Pafulin, Sicorten Plus). Its healthcare segment, Natural Dailyhealth, produces plant extracts and health foods, while Botai handles cosmeceuticals like collagen fillers. The company also has hotel operations in China.

Therapeutic areas: OtherDermatology
Modalities: Small MoleculeNatural ProductsMedical Device
Industry: Biotech

Partnerships

InterContinental Hotels Group (hotel operations)Tianjin Robustnique Biotechnology Co., Limited (skincare development)

Beyond the preview

Go deeper on Cathay International Holdings Limited.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cathay International Holdings Limited.

Explore the full profile